Heron Therapeutics Inc.   (HRTX) - NASDAQCM

  Revenue / EPS Summary *  
 
 Fiscal Quarter 2019
(Fiscal Year)
2018
(Fiscal Year)
2017
(Fiscal Year)
March      
   Revenue $31,602(t) $11,567(t) $3,632(t)
   EPS -0.8 (3/31/2019) -0.81 (3/31/2018) -1 (3/31/2017)
   Dividends N/A N/A N/A
June      
   Revenue $36,659(t) $17,277(t) $8,510(t)
   EPS -0.63 (6/30/2019) -0.52 (6/30/2018) -0.79 (6/30/2017)
   Dividends N/A N/A N/A
September      
   Revenue   $19,786(t) $8,572(t)
   EPS   -0.48 (9/30/2018) -0.76 (9/30/2017)
   Dividends   N/A N/A
December  (FYE)      
   Revenue   $28,844(t) $10,053(t)
   EPS   -0.63 (12/31/2018) -1.1 (12/31/2017)
   Dividends   N/A N/A
Totals      
   Revenue $68,261(t) $77,474(t) $30,767(t)
   EPS -1.43 -2.44 -3.65
   Dividends N/A N/A N/A
   Previous 3 Years
 
 
©2019, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.